Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$563,783,150
New position
Shares Held
2,858,651
first reported quarter
Ownership
0.184%
of shares outstanding
% of Portfolio
5.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.93594880942095.ToString("F0")%
Shared 0.ToString("F0")%
None 0.06405119057905286.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026THORNBURG INVESTMENT MANAGEMENT INC holds $1,242,934,030 across 7 Drug Manufacturers - General names. AZN ranks #1 (45.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
2,858,651 | $563,783,150 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,728,673 | $448,522,075 | |
| 3 | ABBV |
AbbVie Inc.
|
502,832 | $109,360,931 | |
| 4 | PFE |
Pfizer Inc
|
2,242,186 | $62,960,582 | |
| 5 | LLY |
ELI LILLY & Co
|
60,178 | $55,349,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
38,400 | $2,328,960 | |
| 7 | NVS |
Novartis AG
|
4,114 | $628,413 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $563,783,150 | 2,858,651 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||